Ryan B Perumpail, MD
Gastroenterology · Bettendorf
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
- Since medical school
- 14 years
- Northwestern University Feinberg Medical School, 2012
Offices
4 locations · Genesis Health System · 262 clinicians in this group
Hospitals listed: Mercyone Genesis · Mercyone Genesis Dewitt Medical Center · Mercyone Genesis Silvis Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Perumpail’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A128296 · Current
Licensed to practise in California · since 2013 · expires 2027-07-31 · Northwestern University Feinberg School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Genesis Hlth System Dba Genesis Mdl Ctr-IlliniSilvis, ILAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 2 of 5 · 57% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
- Genesis Medical Center-DavenportDavenport, IAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 2 of 5 · 58% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.43 (1.13 to 1.73), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.9 (1.21 to 2.58) · 5,057 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.216, Oct 2024 – Sep 2025
- Mercyone Genesis Dewitt Medical CenterDewitt, IACritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Trinity Health, which runs 105 hospitals in 16 states96% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for Genesis Hlth System Dba Genesis Mdl Ctr-Illini
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 0 better, 5 the same, 0 worse of 5 measures. Readmissions: 1 better, 8 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.23 to 2.37) · 143 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.55 to 1.49) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8 · 66 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.8 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.6 · 84 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 109 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.2 · 61 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 749 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,177 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,114 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.08 (1.58 to 6.59) · 234 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.38) · 60 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.59 (0.88 to 4.29) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.39 (1.6 to 21.18) · 58 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.04 (0.78 to 9.31) · 56 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.24) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.45 (0 to 1.58) · 794 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 92 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 3.072 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.244 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 45 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.1 · 145 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.4 · 98 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -11.3 · 112 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 196 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3 to 7.6) · 44 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (6.8 to 14.5) · 44 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 89 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.5 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10 to 18.4) · 194 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 159 cases | No different | Jan 2024 – Dec 2024 |
What patients said (361 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 3 |
| Recommend hospital | 2 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 66% |
| Nurses "always" explained things so they could understand | 66% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 57% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Genesis Medical Center-Davenport
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.43 (1.13 to 1.73) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.9 (1.21 to 2.58) · 5,057 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.216 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.9) · 1,401 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.09 (142.47 to 241.72) · 120 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 42 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.8 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 214 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.3 · 556 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 700 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 341 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.5 · 4,165 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.09 to 0.49) · 7,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.36 (0.16 to 0.55) · 7,648 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.52 (1.59 to 5.45) · 2,168 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.15 (0 to 2.58) · 980 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.76 (0.35 to 3.17) · 2,123 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.78 (4.01 to 15.54) · 989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.14 (3.78 to 10.5) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.56 (0.12 to 3.01) · 362 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 409 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.135 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.477 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.771 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.796 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 439 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.8 · 851 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 23.3 · 318 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 24.2 · 666 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 3.1 · 791 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.6 · 1,010 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.2 (4.5 to 8.6) · 250 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.9 (10.1 to 16.1) · 250 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.7 · 63 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 357 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.5 to 19.1) · 171 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 743 cases | No different | Jan 2024 – Dec 2024 |
What patients said (889 patients answered, 23% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 65% |
| Doctors "always" listened carefully | 68% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 66% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 58% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Mercyone Genesis Dewitt Medical Center
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for pneumonia patientsComplications and deaths | 15 · 33 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 57 cases | None | Jul 2024 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -15.6 · 29 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 26 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (9.8 to 18) · 180 cases | No different | Jan 2022 – Dec 2024 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 89% |
| Staff "always" explained | 76% |
| Yes, staff "did" give patients this information | 81% |
| Patients who gave a rating of "9" or "10" (high) | 86% |
| "Always" quiet at night | 57% |
| "YES", patients would definitely recommend the hospital | 96% |
Original Medicare doctor bills
$155,875
Medicare paid this office $155,875 for 571 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 232 | $41,081 | $172 |
| New patient visit (45+ min) | 189 | $20,260 | $107 |
| Imaging of digestive tract done from the inside of the digestive tract | 34 | $17,694 | $520 |
| Return visit (30+ min) | 167 | $15,894 | $86 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | 78 | $8,911 | $114 |
See all 17 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 232 | $41,081 | $172 |
| New patient visit (45+ min) | 189 | $20,260 | $107 |
| Imaging of digestive tract done from the inside of the digestive tract | 34 | $17,694 | $520 |
| Return visit (30+ min) | 167 | $15,894 | $86 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | 78 | $8,911 | $114 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 207 | $7,835 | $35 |
| Biopsy of large bowel using a flexible endoscope | 198 | $7,759 | $38 |
| Removal of large bowel tissue using a flexible endoscope | 28 | $6,796 | $243 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 41 | $6,303 | $154 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 44 | $3,334 | $72 |
| Removal of external hemorrhoids by rubber banding | 26 | $2,534 | $91 |
| Diagnostic exam of large bowel using a flexible endoscope | 22 | $2,464 | $112 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 30 | $1,855 | $46 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 17 | $1,813 | $76 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,446 | $96 |
| Short return visit (20+ min) | 18 | $992 | $55 |
| Injection beneath lining of large bowel using a flexible endoscope | 17 | $198 | $12 |
Procedures Medicare counted
| Colonoscopy | 632 | More than 99% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 520 | More than 99% of doctors who do this |
Procedures year by year
| Procedure | 2016 | 2017 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | – | – | 74 | 214 | 194 | 239 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | – | – | 85 | 196 | 191 | 227 |
| Biopsy of large bowel using a flexible endoscope | – | – | 63 | 192 | 181 | 204 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | – | – | 30 | 81 | 65 | 78 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | – | – | 12 | 29 | 39 | 46 |
| Removal of large bowel tissue using a flexible endoscope | – | – | 17 | 37 | 19 | 28 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
571 Original Medicare patients in 2024. Average age 73 · Under 65 3% · 85 and older 7% · Women 51% · Also on Medicaid 5% · Health risk score 1.08. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Coronary heart disease 32% · Diabetes 27% · Chronic kidney disease 24% · Depression 23% · Atrial fibrillation 20% · Cancer 19% · COPD 17% · Heart failure 15% · Stroke 8% · Dementia 5%.
The office billed $787,108, Medicare allowed $198,316 and paid $155,875; for 1,520 services of 44 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 571 | 1,520 | 73 | 1.08 | $787,108 | $155,875 |
| 2023 | 454 | 1,263 | 73 | 1.21 | $641,333 | $126,092 |
| 2022 | 518 | 1,360 | 73 | 1.24 | $897,044 | $140,687 |
| 2021 | 217 | 579 | 73 | 1.11 | $563,222 | $64,434 |
| 2017 | 147 | 369 | 77 | 3.73 | $224,450 | $41,998 |
| 2016 | 502 | 1,766 | 79 | 3.01 | $973,225 | $184,203 |
| 2015 | 205 | 642 | 82 | 2.85 | $293,200 | $66,581 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 190 | $34,083 | $176 |
| New patient visit (45+ min) | 208 | $22,173 | $107 |
| Imaging of digestive tract done from the inside of the digestive tract | 20 | $10,803 | $540 |
| Return visit (30+ min) | 82 | $7,276 | $88 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | 63 | $6,768 | $104 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 181 | $6,753 | $35 |
| Biopsy of large bowel using a flexible endoscope | 176 | $5,519 | $30 |
| Removal of large bowel tissue using a flexible endoscope | 19 | $4,716 | $248 |
| Long return visit (40+ min) | 30 | $3,796 | $115 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 36 | $2,946 | $76 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 30 | $2,874 | $57 |
| Removal of external hemorrhoids by rubber banding | 20 | $1,805 | $86 |
| Diagnostic exam of large bowel using a flexible endoscope | 16 | $1,670 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,329 | $89 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,110 | $85 |
2022: 16 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 206 | $36,347 | $170 |
| New patient visit (45+ min) | 199 | $22,262 | $112 |
| Removal of large bowel tissue using a flexible endoscope | 37 | $9,346 | $253 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | 78 | $9,250 | $114 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 184 | $7,425 | $38 |
| Biopsy of large bowel using a flexible endoscope | 185 | $6,985 | $36 |
| Return visit (30+ min) | 72 | $6,220 | $84 |
| Long return visit (40+ min) | 21 | $2,757 | $120 |
| New patient visit (30+ min) | 32 | $2,358 | $74 |
| Diagnostic exam of large bowel using a flexible endoscope | 20 | $2,089 | $104 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 27 | $1,916 | $66 |
| Removal of external hemorrhoids by rubber banding | 23 | $1,914 | $83 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,541 | $103 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 12 | $1,084 | $68 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 12 | $918 | $66 |
| Short return visit (20+ min) | 11 | $764 | $69 |
2021: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 74 | $11,885 | $161 |
| New patient visit (45+ min) | 87 | $10,604 | $122 |
| Removal of large bowel tissue using a flexible endoscope | 17 | $4,278 | $252 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | 29 | $3,443 | $115 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 83 | $3,211 | $38 |
| New patient visit (60+ min) | 19 | $3,186 | $168 |
| Return visit (30+ min) | 24 | $2,359 | $98 |
| Long return visit (40+ min) | 17 | $2,198 | $129 |
| Biopsy of large bowel using a flexible endoscope | 63 | $2,079 | $33 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,789 | $163 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,516 | $138 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,130 | $103 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 12 | $747 | $62 |
2017: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $17,579 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $12,821 | $167 |
| Critical care, first 30-74 minutes | 13 | $6,270 | $184 |
| Hospital discharge day management, more than 30 minutes | 23 | $2,121 | $92 |
| Initial hospital observation care per day, typically 70 minutes | 15 | $2,055 | $137 |
2016: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 238 | $76,275 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 245 | $43,305 | $165 |
| Critical care, first 30-74 minutes | 47 | $16,585 | $188 |
| Hospital discharge day management, more than 30 minutes | 143 | $13,632 | $91 |
| Initial hospital observation care per day, typically 70 minutes | 43 | $6,752 | $157 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 40 | $6,208 | $127 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 59 | $5,680 | $60 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 21 | $3,229 | $108 |
| Nursing facility discharge management, more than 30 minutes | 29 | $2,974 | $90 |
| Hospital observation care on day of discharge | 31 | $1,924 | $62 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 11 | $1,388 | $66 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 24 | $1,214 | $47 |
| Advance care planning, first 30 minutes | 17 | $1,136 | $67 |
2015: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $20,854 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $11,929 | $173 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 42 | $6,717 | $78 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 24 | $4,988 | $116 |
| Critical care, first 30-74 minutes | 12 | $4,174 | $190 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 28 | $4,124 | $142 |
| Hospital discharge day management, more than 30 minutes | 40 | $3,778 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,848 | $62 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 16 | $1,788 | $112 |
Medicaid work
$3,680 in 2024
Medicaid paid $3,680 for 46 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 30 | $2,377 |
| Upper gastrointestinal endoscopy with biopsy | 16 | $1,303 |
| 2024 | 46 | 2 | 17 | $3,680 |
| 2023 | 490 | 4 | 26 | $43,784 |
| 2022 | 764 | 4 | 30 | $92,411 |
| 2021 | 94 | 2 | 20 | $7,937 |
See the largest Medicaid services in earlier years
2023
| New patient visit (45+ min) | 226 | $18,222 |
| COLONOSCOPY W/LESION REMOVAL | 69 | $10,726 |
| Upper gastrointestinal endoscopy with biopsy | 145 | $10,376 |
| COLONOSCOPY AND BIOPSY | 50 | $4,460 |
2022
| COLONOSCOPY W/LESION REMOVAL | 151 | $37,527 |
| New patient visit (45+ min) | 236 | $20,240 |
| COLONOSCOPY AND BIOPSY | 191 | $18,390 |
| Upper gastrointestinal endoscopy with biopsy | 186 | $16,254 |
2021
| New patient visit (45+ min) | 63 | $5,975 |
| Upper gastrointestinal endoscopy with biopsy | 31 | $1,962 |
Drugs they prescribed that Part D paid
$370,341
Pharmacies billed $370,341 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,478) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
1,146 generic and fewer than 11 brand-name prescriptions · $370,341 in drug cost · 58 antibiotic prescriptions to 35 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xifaxan | 29 | $71,574 | $2,468 |
| Linzess | 19 | $23,765 | $1,251 |
| Sod Sulf-Potass Sulf-Mag Sulf | 364 | $23,254 | $64 |
| Creon | 11 | $19,184 | $1,744 |
| Mesalamine | 15 | $10,226 | $682 |
See all 21 drugs
| Xifaxan | 29 | $71,574 | $2,468 |
| Linzess | 19 | $23,765 | $1,251 |
| Sod Sulf-Potass Sulf-Mag Sulf | 364 | $23,254 | $64 |
| Creon | 11 | $19,184 | $1,744 |
| Mesalamine | 15 | $10,226 | $682 |
| Suflave | 69 | $8,393 | $122 |
| Dexlansoprazole Dr | 17 | $5,540 | $326 |
| Budesonide Dr | 15 | $5,075 | $338 |
| Plenvu | 23 | $3,318 | $144 |
| Budesonide Ec | 20 | $3,022 | $151 |
| Pantoprazole | 218 | $2,823 | $13 |
| Omeprazole | 253 | $2,578 | $10 |
| Esomeprazole Magnesium | 23 | $1,135 | $49 |
| Famotidine | 113 | $1,091 | $10 |
| Sucralfate | 22 | $821 | $37 |
| Gavilyte-G | 43 | $703 | $16 |
| Cholestyramine | 12 | $609 | $51 |
| Sulfasalazine | 14 | $420 | $30 |
| Peg-3350 and Electrolytes | 15 | $213 | $14 |
| Enulose | 23 | $49 | $2 |
| Lactulose | 26 | $38 | $1 |
Year by year
| 2024 | 1,478 | 748 | 0% (0) | None | $370,341 |
| 2023 | 967 | 523 | 0% (0) | None | $220,485 |
| 2022 | 863 | 471 | 0% (0) | 54% | $192,678 |
| 2021 | 334 | 185 | 0% (0) | 40% | $42,523 |
| 2020 | 125 | 35 | 0% (0) | None | $4,487 |
| 2019 | 156 | None | 0% (0) | None | $1,460 |
| 2018 | 84 | None | 0% (0) | None | $16,021 |
| 2017 | 224 | 26 | None | 24% | $15,127 |
| 2016 | 941 | 99 | 3% (29) | None | $47,963 |
| 2015 | 273 | 40 | 4% (11) | None | $11,558 |
| 2014 | 17 | None | None | None | $593 |
| 2013 | 15 | None | 0% (0) | None | $866 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Xifaxan | 24 | $66,495 | $2,771 |
| Sod Sulf-Potass Sulf-Mag Sulf | 236 | $19,101 | $81 |
| Mesalamine | 15 | $14,189 | $946 |
| Plenvu | 46 | $6,841 | $149 |
| Budesonide Er | 16 | $4,797 | $300 |
| Suflave | 34 | $4,424 | $130 |
| Suprep | 34 | $3,806 | $112 |
| Omeprazole | 197 | $2,958 | $15 |
| Pantoprazole | 67 | $1,175 | $18 |
| Famotidine | 50 | $1,149 | $23 |
| Gavilyte-G | 28 | $544 | $19 |
| Sulfasalazine | 14 | $99 | $7 |
| Lactulose | 25 | $49 | $2 |
| Enulose | 21 | $37 | $2 |
2022: 13 drugs
| Xifaxan | 17 | $42,628 | $2,508 |
| Suprep | 211 | $24,199 | $115 |
| Mesalamine | 18 | $20,200 | $1,122 |
| Budesonide Er | 31 | $14,050 | $453 |
| Plenvu | 55 | $7,647 | $139 |
| Sutab | 45 | $7,323 | $163 |
| Budesonide Ec | 15 | $6,804 | $454 |
| Sod Sulf-Potass Sulf-Mag Sulf | 43 | $3,475 | $81 |
| Budesonide Dr | 11 | $3,074 | $279 |
| Omeprazole | 160 | $2,395 | $15 |
| Pantoprazole | 45 | $669 | $15 |
| Famotidine | 40 | $595 | $15 |
| Peg-3350 and Electrolytes | 11 | $149 | $14 |
2021: 10 drugs
| Suprep | 77 | $8,560 | $111 |
| Sutab | 27 | $4,113 | $152 |
| Sucralfate | 11 | $1,503 | $137 |
| Pantoprazole | 53 | $854 | $16 |
| Rosuvastatin | 21 | $568 | $27 |
| Omeprazole | 28 | $504 | $18 |
| Famotidine | 13 | $458 | $35 |
| Lidocaine Hcl Viscous | 12 | $96 | $8 |
| Lisinopril | 20 | $91 | $5 |
| Ciprofloxacin | 11 | $37 | $3 |
2020: 4 drugs
| Rosuvastatin | 20 | $360 | $18 |
| Pantoprazole | 29 | $166 | $6 |
| Lisinopril | 23 | $98 | $4 |
| Ciprofloxacin | 18 | $27 | $2 |
2019: 4 drugs
| Rosuvastatin | 36 | $624 | $17 |
| Pantoprazole | 36 | $215 | $6 |
| Metoprolol | 33 | $162 | $5 |
| Lisinopril | 35 | $141 | $4 |
2018: 4 drugs
| Rosuvastatin | 17 | $275 | $16 |
| Pantoprazole | 18 | $104 | $6 |
| Metoprolol | 18 | $87 | $5 |
| Lisinopril | 17 | $68 | $4 |
2017: 2 drugs
| Omega-3 Acid Ethyl Esters | 17 | $1,556 | $92 |
| Olmesartan Medoxomil | 11 | $1,351 | $123 |
2016: 26 drugs
| Namenda Xr | 16 | $2,683 | $168 |
| Eliquis | 14 | $2,571 | $184 |
| Omega-3 Acid Ethyl Esters | 15 | $1,279 | $85 |
| Digox | 17 | $485 | $29 |
| Mirtazapine | 32 | $424 | $13 |
| Levothyroxine | 24 | $361 | $15 |
| Gabapentin | 24 | $331 | $14 |
| Pantoprazole | 31 | $314 | $10 |
| Metoprolol | 32 | $294 | $9 |
| Amlodipine Besylate | 31 | $286 | $9 |
| Atorvastatin | 24 | $271 | $11 |
| Polyethylene Glycol 3350 | 15 | $260 | $17 |
| Clopidogrel | 22 | $255 | $12 |
| Fluconazole | 12 | $248 | $21 |
| Hydralazine | 13 | $247 | $19 |
| Tamsulosin | 15 | $217 | $14 |
| Levetiracetam | 18 | $210 | $12 |
| Donepezil | 22 | $208 | $9 |
| Divalproex | 13 | $206 | $16 |
| Risperidone | 12 | $204 | $17 |
| Warfarin | 23 | $196 | $9 |
| Hydrocodone-Acetaminophen | 11 | $162 | $15 |
| Terazosin | 11 | $117 | $11 |
| Quetiapine | 12 | $115 | $10 |
| Lisinopril | 16 | $93 | $6 |
| Furosemide | 17 | $76 | $4 |
2015: 2 drugs
| Fluticasone Propionate | 11 | $146 | $13 |
| Amlodipine Besylate | 11 | $103 | $9 |
Money from drug and device companies
$5,022 in 2025
| 2025 | 3 | 8 | $4,800 | $5,022 |
| 2024 | 1 | 5 | $4,500 | $4,767 |
| 2022 | 3 | 3 | None | $263 |
| 2021 | 3 | 10 | None | $50,659 |
| 2020 | 4 | 4 | $250 | $542 |
| 2019 | 2 | 3 | None | $255 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Phathom Pharmaceuticals | Voquezna | $4,877 | 6 payments
|
| Medtronic | Interstim | $79 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $67 | 1 payment
|
See all 8 published payments
| Phathom Pharmaceuticals | Meals · 2025-09-16 | Voquezna | $15 |
| Phathom Pharmaceuticals | Paid to speak or teach · 2025-06-18 | Voquezna | $2,400 |
| Phathom Pharmaceuticals | Meals · 2025-05-28 | Voquezna | $5 |
| Regeneron Healthcare Solutions | Meals · 2025-05-22 | Dupixent | $67 |
| Phathom Pharmaceuticals | Meals · 2025-05-04 | Voquezna | $50 |
| Phathom Pharmaceuticals | Meals · 2025-04-23 | Voquezna | $7 |
| Medtronic | Meals · 2025-01-22 | Interstim | $79 |
| Phathom Pharmaceuticals | Paid to speak or teach · 2025-01-03 | Voquezna | $2,400 |
See earlier years (2024, 2022, 2021, 2020, 2019)
2024: $4,767
| Phathom Pharmaceuticals | Voquezna | $4,767 | 5 payments
|
2022: $263
| Boston Scientific | General - Therapies | $162 | 1 payment
|
| Ethicon US | Linx Reflux Management System | $79 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Plenvu | $23 | 1 payment
|
2021: $50,659
| Boston Scientific | General Biliary Devices | $50,433 | 7 payments
|
| Olympus America | Visiglide | $215 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $11 | 1 payment
|
2020: $542
| Ambu A/S | None | $250 | 1 payment
|
| Janssen Scientific Affairs | Stelara | $124 | 1 payment
|
| Janssen Biotech | Tremfya | $99 | 1 payment
|
| Boston Scientific | General - Biliary Devices | $69 | 1 payment
|
2019: $255
| Boston Scientific | Orise | $151 | 2 payments
|
| Endogastric Solutions | Esophyx | $104 | 1 payment
|
Checkups this office reported
8 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 65.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 74%That's more than half. | 451 |
| Breast cancer screeningEligible women who got a mammogram | 66%That's more than half. | 398 |
| Checked for fall riskOlder patients screened for fall risk | 50%That's more than half. | 555 |
| Colon cancer screeningEligible adults who got a colon cancer test | 89%That's most of the people this applied to. | 985 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 55%That's more than half. Worse on this measure. | 174 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 88%That's most of the people this applied to. | 16,029 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 96%That's most of the people this applied to. | 25,431 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 73%That's more than half. | 465 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Collects patient feedback
- Did a security review of patient data
- Drug Cost Transparency
- Exchanges records both ways with other health systems
- ONC-ACB Surveillance Attestation
- Promoting Clinician Well-Being
- Reports cases to public health electronically
- Reports immunizations to the state registry
- Reports to public-health surveillance
- Tobacco use
Professional record
- NPI
- 1649546623
- Licence
- CA A128296, IA MD-48522California A128296: Current · expires 2027-07-31
- Trained
- Northwestern University Feinberg Medical School, 2012 · 14 years ago
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 2222 53rd Ave, Bettendorf, IA, 52722
- NPI first listed
- 2012-03-24
- NPI last updated
- 2021-08-13
- NPI record certified
- 2021-08-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305
This office lists an electronic records connection.